Drug-delivery Ca-Mg Silicate Scaffolds Encapsulated in PLGA

Authors

A. Jadidi, K. N. Toosi University of Technology
E. Salahinejad, K.N.Toosi University of TechnologyFollow
E. Sharifi, Hamadan University of Medical Sciences
Lobat Tayebi, Marquette UniversityFollow

Document Type

Article

Publication Date

11-15-2020

Publisher

Elsevier

Source Publication

International Journal of Pharmaceutics

Source ISSN

0378-5173

Abstract

The aim of this work is to develop dual-functional scaffolds for bone tissue regeneration and local antibiotic delivery applications. In this respect, bioresorbable bredigite (Ca₇MgSi₄O₁₆) porous scaffolds were fabricated by a foam replica method, loaded with vancomycin hydrochloride and encapsulated in poly lactic-co-glycolic acid (PLGA) coatings. Field emission scanning electron microscopy, Archimedes porosimetry and Fourier-transform infrared spectroscopy were used to characterize the structure of the scaffolds. The drug delivery kinetics and cytocompatibility of the prepared scaffolds were also studied in vitro. The bare sample exhibited a burst release of vancomycin and low biocompatibility with respect to dental pulp stem cells based on the MTT assay due to the fast bioresorption of bredigite. While keeping the desirable characteristics of pores for tissue engineering, the biodegradable PLGA coatings modified the drug release kinetics, buffered physiological pH and hence improved the cell viability of the vancomycin-loaded scaffolds considerably.

Comments

Accepted version. International Journal of Pharmaceutics, Vol. 589 (November 15, 2020): 119855. DOI. © 2020 Elsevier. Used with permission.

Recommended Citation

Jadidi, A.; Salahinejad, E.; Sharifi, E.; and Tayebi, Lobat, "Drug-delivery Ca-Mg Silicate Scaffolds Encapsulated in PLGA" (2020). School of Dentistry Faculty Research and Publications. 443.
https://epublications.marquette.edu/dentistry_fac/443